Trump touts COVID-19 convalescent plasma treatment, but some say it’s still unproven
5 years ago 1 min read
The Food and Drug Administration announced Sunday it was issuing an emergency authorization for convalescent plasma treatment in hospitalized COVID-19 patients.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push